Status:
COMPLETED
Device for Breathing Frequency Monitoring in Muscular Dystrophy
Lead Sponsor:
IRCCS Eugenio Medea
Conditions:
Muscular Dystrophies
Eligibility:
All Genders
Phase:
NA
Brief Summary
Patients at risk of developing respiratory dysfunctions, such as patients with severe forms of muscular dystrophy, need a careful respiratory assessment, and periodic follow-up visits to monitor the p...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- documented DMD or LGMD2
- loss of independent ambulation (wheelchair-bound patients)
- ability to understand and follow test instructions and to report pain and discomfort.
- Exclusion criteria:
- presence of metal implants and cardiac pacemakers
- relevant concomitant comorbidities (e.g.epilepsy)
- behaviour and/or psychiatric disorders (e.g. emotional problems, anxiety, panic attacks).
Exclusion
Key Trial Info
Start Date :
July 29 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2019
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04313595
Start Date
July 29 2018
End Date
July 15 2019
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Medea
Bosisio Parini, Lecco, Italy, 23842